Boston Pharmaceuticals Competitors and Similar CompaniesClear all
Boston Pharmaceuticals's competitors and similar companies include OriGene Technologies, BioCryst Pharmaceuticals, Fortress Biotech and Bioiberica.
 BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Fortress Biotech Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. |  Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. | |||
Founding Date | Founding Date 2016 | Founding Date 1996 | Founding Date 1986 | Founding Date 2006 | Founding Date 1975 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Rockville, US HQ Herford, DE Newark, US Windham, US | Locations Durham, US HQ Hoover, US | Locations New York, US HQ Waltham, US | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES |
Employees | Employees 81 | Employees 1242% increase | Employees 14040% increase | Employees 10146% decrease | Employees 332 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) 55.7 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) $63.3m (FY, 2025) | Revenue (est.) $346.7m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $19.1m (FY, 2025) | Cost of goods $20.9m (FY, 2025) | Cost of goods $190.3m (FY, 2018) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $855.8m (FY, 2025) | Gross profit $42.3m (FY, 2025) | Gross profit $156.4m (FY, 2018) |
Net income | Net income N/A | Net income N/A | Net income $263.9m (FY, 2025) | Net income ($32.9m) (FY, 2025) | Net income $40.5m (FY, 2018) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 69.6m | Total funding raised $ 1.9m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
OriGene Technologies
HQ
Rockville, US
OriGene Technologies is a company specializing in biotechnology research.
View companyBioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View companyFortress Biotech
HQ
New York, US
Employees
101↓ 46% decrease
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
View companyBioiberica
HQ
Esplugues de Llobregat, ES
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View company